Since SPP is an essential gene, we previously used a tamoxifen-inducible Cre system to deplete SPP and showed that while SPP was not completely depleted, replication in the eye and eye disease both were decreased, and latency was reduced [24]. The gene discussed is HM13; the disease is eye disorder.